Aspire Biopharma (ASBP) Institutional Ownership $0.34 +0.02 (+5.09%) As of 03:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFDA EventsOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Aspire Biopharma (NASDAQ:ASBP)CurrentInstitutional OwnershipPercentage19.17%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$266.85KNumber ofInstitutional Sellers(last 12 months)0 Get ASBP Insider Trade Alerts Want to know when executives and insiders are buying or selling Aspire Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Aspire Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/5/2025 Optivise Advisory Services LLC235,106$63K0.0%+120.9%0.475% 7/30/2025 Crewe Advisors LLC626,854$169K0.0%+100.0%1.266% 7/9/2025 Procyon Advisors LLC648,411$174K0.0%+558.3%1.309% (Data available from 1/1/2016 forward) ASBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ASBP shares? During the previous two years, the following institutional investors and hedge funds held shares of Aspire Biopharma shares: Procyon Advisors LLC ($174K), and Crewe Advisors LLC ($169K), Optivise Advisory Services LLC ($63K).Learn more on Aspire Biopharma's institutional investors. What percentage of Aspire Biopharma's stock is owned by institutional investors? 19.17% of Aspire Biopharma's stock is owned by institutional investors. Learn more on ASBP's institutional investor holdings. Which institutional investors have been buying Aspire Biopharma's stock? The following institutional investors have purchased Aspire Biopharma's stock in the last 24 months: Procyon Advisors LLC ($549.91K), Crewe Advisors LLC ($313.43K), and Optivise Advisory Services LLC ($128.66K). How much institutional buying is happening at Aspire Biopharma? Institutional investors have bought a total of 991,998 shares in the last 24 months. This purchase volume represents approximately $266.85K in transactions. Related Companies PMVP Major Shareholders ARTV Major Shareholders IMA Major Shareholders CRVO Major Shareholders GNTA Major Shareholders PYXS Major Shareholders ATRA Major Shareholders ASRT Major Shareholders QNTM Major Shareholders STRO Major Shareholders This page (NASDAQ:ASBP) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspire Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspire Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
